How Often Do You Inject Weight Loss Drugs Like Mounjaro and Wegovy?

Mounjaro and Wegovy are both once-weekly subcutaneous injections — same day every week, not daily.
Treatment begins at a low starter dose (2.5 mg for Mounjaro, 0.25 mg for Wegovy) and is increased gradually by your prescriber, typically in four-week steps.
Each Mounjaro KwikPen contains four weekly doses; each Wegovy pen delivers one weekly dose, your prescriber confirms which applies to your treatment.
Missing a dose or changing injection day should be managed with your prescriber and the Patient Information Leaflet, not self-adjusted.

Both Mounjaro (tirzepatide) and Wegovy (semaglutide) are injected once a week — the same day each week, chosen by you and confirmed with your prescriber. That single weekly injection is all that's needed to keep active levels of the medicine steady in your body. Neither drug requires daily dosing, and neither is taken as a tablet (though an oral semaglutide option, Wegovy tablets, now exists separately). Because these are prescription-only medicines requiring clinical assessment, the exact schedule is set by a GPhC-registered prescriber, not chosen off a shelf.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The weekly injection schedule in practice: timing, titration and what to expect

Once a week, but does the day or time matter?

The short answer is: pick a day that suits your routine, then stick to it. Both Mounjaro and Wegovy are designed around a seven-day cycle, and consistency helps keep drug levels stable. Most people anchor it to something predictable, a Sunday evening after dinner, a Monday morning before work. The exact time of day is flexible; what matters is that it stays roughly the same each week.

If you need to shift your injection day, the Patient Information Leaflet explains the minimum gap to leave between doses, always follow that guidance or speak to your prescriber rather than guessing. Understanding how often you use weight loss injections, and what that weekly rhythm actually involves, is worth doing before you start so you can plan around travel or shift work in advance.

The injection itself goes under the skin (abdomen, thigh or upper arm) rotating the site each week to avoid localised irritation. The Mounjaro KwikPen is a multi-dose pen containing four weeks of treatment in a single device. Wegovy uses individual pre-filled pens, one per week. When your order arrives via DPD in plain, unbranded packaging, the contents are ready to use; you don't assemble anything. A glance at the full guide to weight loss injections covers technique and storage in more detail.

Why does the dose change if the frequency stays the same?

The once-weekly rhythm stays constant, but the dose steps up over time. For Mounjaro, treatment opens at 2.5 mg, a dose whose job is to let your body adjust to the medicine, not to drive weight loss directly. The prescriber then increases the dose roughly every four weeks, moving through 5 mg, 7.5 mg, 10 mg, 12.5 mg and up to 15 mg, aiming for the highest dose you tolerate well.

Wegovy follows a similar logic: 0.25 mg, then 0.5 mg, 1 mg, 1.7 mg and 2.4 mg, with a newer 7.2 mg dose now available following MHRA approval in April 2026. The gradual ramp is the reason most side effects (largely nausea and digestive discomfort) are manageable for most people. Moving too fast causes more symptoms; holding at a dose that feels right is normal clinical practice, not a setback.

According to the NHS tirzepatide page, the titration schedule is determined by how you're tolerating the medicine, not by a fixed calendar. Your prescriber at a service like nume reviews your progress before any dose change. If you're wondering how often you inject weight loss injections and whether injecting more frequently would speed results, the answer is that it would not, and it would increase side effects significantly.

What actually happens between injections?

The medicines are engineered for a long half-life, meaning a single weekly dose maintains meaningful blood levels throughout all seven days. You won't feel a sharp peak on injection day followed by a trough, the pharmacology is designed to avoid that pattern. Appetite suppression and the slowing of gastric emptying that both drugs produce tend to be fairly consistent across the week once you've been on a stable dose for a few weeks.

That said, the first few days after a dose increase can feel different. Some people notice a stronger effect on appetite or more nausea in the 24–48 hours post-injection, which typically settles. Staying well hydrated, eating smaller meals and keeping protein intake up all help. The overview of weight loss injections covers lifestyle support alongside treatment in more detail. If symptoms feel serious or persistent, contact your prescriber rather than waiting for the next scheduled review.

For anyone curious about B12 injections alongside weight loss treatment, the frequency and rationale differ entirely, B12 is a separate nutritional consideration, not a GLP-1 medicine, and is managed differently.

Does the schedule change if you're on the NHS versus a private service?

The clinical schedule (once-weekly injection, four-weekly titration) is the same regardless of where you're prescribed. What differs is the access route. NHS availability for Mounjaro is currently limited to people meeting the phased NICE eligibility criteria (NICE technology appraisal TA1026), which sets strict BMI and comorbidity thresholds. Wegovy is available via specialist weight management services under NICE TA875, with waiting lists at many centres.

A regulated private service operates the same clinical standards but without the NHS waiting period. You can read about where to obtain weight loss injections legally and what to check when choosing a provider, GPhC registration is the starting point. The treatment options page summarises what's available and the eligibility picture for each. Whatever the route, the prescription defines the schedule, and a prescriber reviews your case before every repeat order. That's not bureaucracy; for a medicine that's titrated over months, it's simply good clinical care.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions